Clinical Trial Update: Compassionate Use of Vidutolimod

View source ↗

Summary

The compassionate-use program for Vidutolimod in patients with melanoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vidutolimod

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Refractory Melanoma | Status: NO_LONGER_AVAILABLE